Literature DB >> 25462664

Smoking cessation abstinence goal in treatment-seeking smokers.

Sharon M Hall1, Yanling Shi2, Gary L Humfleet2, Ricardo F Muñoz3, Victor I Reus2, Judith J Prochaska4.   

Abstract

INTRODUCTION: Baseline abstinence goal is a robust predictor of cigarette abstinence. However, important questions about goal remain unanswered. These include variables correlating with goal, changes in goal, relationship of goal and abstinence status over time, and predictors of change. The current study aimed to address these questions.
METHOD: Participants were treatment-seeking volunteers in two clinical trials. In Clinical Trial 1 (N=402), participants smoked ≥10 cigarettes per day (CPD) and were ≥50years of age. In Clinical Trial 2 (N=406), participants smoked ≥10 CPD, smoked within 30min of arising, and were ≥18years of age. The outcome variables were biochemically verified 7-day abstinence from cigarettes at weeks 12, 24, 52, and 104. Abstinence goal, demographic, psychological, and smoking related variables were assessed via standard instruments.
RESULTS: At baseline, the greater the desire to quit and one's expectations of success, and the lesser the educational level, the more likely participants were to have a quit forever goal. Throughout the two-year study, abstinence from cigarettes and a lower educational level were correlated with a goal of quit forever; 37% of participants changed goal. There were no predictors of goal change. Abstinence goal was related to abstinence status across the study period. The goal predicted abstinence status at subsequent assessments, even when status was controlled.
CONCLUSION: Lesser educational levels were consistent predictors of a more stringent goal. Abstinence goal changes over time. These findings suggest that repeated counseling about goal is advisable and participants would benefit from such counseling, independent of demographic characteristics and smoking status.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Abstinence goal; Abstinence status; Smoking cessation; Tobacco

Mesh:

Substances:

Year:  2014        PMID: 25462664      PMCID: PMC4273741          DOI: 10.1016/j.addbeh.2014.11.012

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  20 in total

1.  Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence.

Authors:  Karl Fagerström
Journal:  Nicotine Tob Res       Date:  2011-10-24       Impact factor: 4.244

2.  The effect of drinking goals at treatment entry on longitudinal alcohol use patterns among adults with alcohol dependence.

Authors:  Orion Mowbray; Amy R Krentzman; Jaclyn C Bradley; James A Cranford; Elizabeth A R Robinson; Andrew Grogan-Kaylor
Journal:  Drug Alcohol Depend       Date:  2013-02-21       Impact factor: 4.492

3.  Using extended cognitive behavioral treatment and medication to treat dependent smokers.

Authors:  Sharon M Hall; Gary L Humfleet; Ricardo F Muñoz; Victor I Reus; Judith J Prochaska; Julie A Robbins
Journal:  Am J Public Health       Date:  2011-06-08       Impact factor: 9.308

4.  The effects of drinking goal on treatment outcome for alcoholism.

Authors:  Spencer Bujarski; Stephanie S O'Malley; Katy Lunny; Lara A Ray
Journal:  J Consult Clin Psychol       Date:  2012-12-10

5.  Factors accounting for cocaine use two years following initiation of continuing care.

Authors:  J R McKay; E Merikle; F D Mulvaney; R V Weiss; J M Koppenhaver
Journal:  Addiction       Date:  2001-02       Impact factor: 6.526

6.  Everything under control? The effects of age, gender, and education on trajectories of perceived control in a nationally representative German sample.

Authors:  Jule Specht; Boris Egloff; Stefan C Schmukle
Journal:  Dev Psychol       Date:  2012-04-30

7.  Changes in psychiatric patients' thoughts about quitting smoking during a smoke-free hospitalization.

Authors:  Dikla Shmueli; Lindsay Fletcher; Stephen E Hall; Sharon M Hall; Judith J Prochaska
Journal:  Nicotine Tob Res       Date:  2008-05       Impact factor: 4.244

8.  Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence.

Authors:  Peter S Hendricks; Kevin L Delucchi; Sharon M Hall
Journal:  Drug Alcohol Depend       Date:  2010-01-21       Impact factor: 4.492

9.  Extended treatment of older cigarette smokers.

Authors:  Sharon M Hall; Gary L Humfleet; Ricardo F Muñoz; Victor I Reus; Julie A Robbins; Judith J Prochaska
Journal:  Addiction       Date:  2009-04-09       Impact factor: 6.526

10.  Smoking cessation outcomes among sexual and gender minority and nonminority smokers in extended smoking treatments.

Authors:  Eric S Grady; Gary L Humfleet; Kevin L Delucchi; Victor I Reus; Ricardo F Muñoz; Sharon M Hall
Journal:  Nicotine Tob Res       Date:  2014-04-11       Impact factor: 4.244

View more
  4 in total

1.  A Pilot Trial Examining African American and White Responses to Algorithm-Guided Smoking Cessation Medication Selection in Persons Living with HIV.

Authors:  Pamela Valera; F Joseph McClernon; Greer Burkholder; Michael J Mugavero; James Willig; Conall O'Cleirigh; Karen L Cropsey
Journal:  AIDS Behav       Date:  2017-07

2.  Cigarette Smoking Cessation Intervention for Buprenorphine Treatment Patients.

Authors:  Sharon M Hall; Gary L Humfleet; James J Gasper; Kevin L Delucchi; David F Hersh; Joseph R Guydish
Journal:  Nicotine Tob Res       Date:  2018-04-02       Impact factor: 4.244

3.  Using a nominal group technique to approach consensus on a resilience intervention for smoking cessation in a lower socioeconomic population.

Authors:  George Tsourtos; Kristen Foley; Paul Ward; Emma Miller; Carlene Wilson; Christopher Barton; Sharon Lawn
Journal:  BMC Public Health       Date:  2019-11-27       Impact factor: 3.295

4.  Success rates in smoking cessation: Psychological preparation plays a critical role and interacts with other factors such as psychoactive substances.

Authors:  Bertrand Joly; Jean Perriot; Philippe d'Athis; Emmanuel Chazard; Georges Brousse; Catherine Quantin
Journal:  PLoS One       Date:  2017-10-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.